Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
QuintilesIMS
Cipla
US Department of Justice
Baxter
Daiichi Sankyo
UBS
Citi

Generated: November 21, 2018

DrugPatentWatch Database Preview

Nesiritide recombinant - Generic Drug Details

« Back to Dashboard

What are the generic sources for nesiritide recombinant and what is the scope of nesiritide recombinant freedom to operate?

Nesiritide recombinant is the generic ingredient in one branded drug marketed by Scios Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for nesiritide recombinant. One supplier is listed for this compound.

Pharmacology for nesiritide recombinant

US Patents and Regulatory Information for nesiritide recombinant

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for nesiritide recombinant

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
QuintilesIMS
Cipla
US Department of Justice
Baxter
Daiichi Sankyo
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.